190 related articles for article (PubMed ID: 12475913)
1. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
[TBL] [Abstract][Full Text] [Related]
2. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
[TBL] [Abstract][Full Text] [Related]
3. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
[TBL] [Abstract][Full Text] [Related]
5. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
6. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
Tseng CC; Zhang XY
Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
10. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
[TBL] [Abstract][Full Text] [Related]
11. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
12. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
Ehses JA; Lee SS; Pederson RA; McIntosh CH
J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
[TBL] [Abstract][Full Text] [Related]
13. Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists.
Naylor J; Suckow AT; Seth A; Baker DJ; Sermadiras I; Ravn P; Howes R; Li J; Snaith MR; Coghlan MP; Hornigold DC
Biochem J; 2016 Sep; 473(18):2881-91. PubMed ID: 27422784
[TBL] [Abstract][Full Text] [Related]
14. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome.
Antonini SR; Baldacchino V; Tremblay J; Hamet P; Lacroix A
Clin Endocrinol (Oxf); 2006 Jan; 64(1):29-36. PubMed ID: 16402925
[TBL] [Abstract][Full Text] [Related]
15. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.
Zhou J; Livak MF; Bernier M; Muller DC; Carlson OD; Elahi D; Maudsley S; Egan JM
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E538-47. PubMed ID: 17505054
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
20. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
Puddu A; Sanguineti R; Montecucco F; Viviani GL
J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
